Two (CD29 and CD42a) out of the five proteins that showed signal differences between heparin plasma EVs from melanoma patients and healthy donors also showed changed signals between heparin and citrate plasma EVs from healthy donors (Figure 6A and Figure S4 in Supplementary Material). This evidence concerns the gene ITGB1 and melanoma.